Alderman C P, Lindsay K S
Pharmacy Department, Repatriation General Hospital, South Australia.
Ann Pharmacother. 1996 Dec;30(12):1411-3. doi: 10.1177/106002809603001210.
To describe a patient in whom the administration of tiaprofenic acid and fosinopril was associated with decreased lithium clearance, resulting in increased serum lithium concentrations.
A woman treated with lithium for bipolar affective disorder was concurrently treated with tiaprofenic acid 200 mg tid for shoulder pain. Previously initiated treatment with fosinopril was maintained during this time. The urinary lithium clearance was decreased during this combination therapy, necessitating a reduction in the lithium dosage.
Lithium is approximately 80% reabsorbed in the proximal tubule, and the addition of tiaprofenic acid may have resulted in enhanced tubular lithium reabsorption. The possible influence of concurrent fosinopril therapy may also have contributed to altered lithium pharmacokinetics in this case.
Serum lithium concentrations should be monitored if patients taking lithium are treated with tiaprofenic acid.
描述一例服用噻洛芬酸和福辛普利后锂清除率降低,导致血清锂浓度升高的患者。
一名因双相情感障碍接受锂治疗的女性,同时因肩部疼痛接受200毫克噻洛芬酸每日三次治疗。在此期间维持先前开始的福辛普利治疗。联合治疗期间尿锂清除率降低,因此需要减少锂剂量。
锂约80%在近端小管重吸收,添加噻洛芬酸可能导致肾小管锂重吸收增强。在该病例中,同时使用福辛普利治疗的潜在影响也可能导致锂药代动力学改变。
服用锂的患者接受噻洛芬酸治疗时,应监测血清锂浓度。